Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $5.05B
- P/E ratio
- —
- EPS
- —
- Volume
- 2,766,256
- 52-week high
- —
- 52-week low
- —
- Open
- $16.30
- Day high
- $16.49
- Day low
- $15.52
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $812.03M | -$68.09M | -$3.22 |
| 2024 | $412.26M | -$281.89M | -$10.66 |
| 2023 | $306.13M | -$341.42M | -$13.24 |
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
- CEO
- David Dean Halbert
- Employees
- 1,769
- Country
- US
- IPO date
- Jun 18, 2025
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Caris Life Sciences, Inc.'s stock price today?
- CAI is trading at $15.56 as of Jul 20, 2026.
- What is Caris Life Sciences, Inc.'s market cap?
- Caris Life Sciences, Inc. (CAI) has a market capitalization of $5.05B.
- Does Caris Life Sciences, Inc. pay a dividend?
- Caris Life Sciences, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Caris Life Sciences, Inc. in?
- Caris Life Sciences, Inc. operates in the Healthcare sector.